Skip to main content

Migard (frovatriptan) 2.5mg Tablets

What is Migard?

Migard contains the active ingredient frovatriptan. This is classed as a “5HT1 agonist”; this group of medicines are also known as “triptans”. Migard Tablets are available for the treatment of headaches associated with migraines. It treats the symptoms effectively, but it does not prevent migraines from happening in advance, and it shouldn’t be taken preventatively.

Start an online consultation with one of our UK-registered GPs
Our GP may advise, prescribe or recommend further tests
Receive certified genuine medication by your chosen delivery method
Migard (Frovatriptan 2.5mg) 2.5mg Tablets Migard (Frovatriptan 2.5mg) 2.5mg Tablet ... £3.47 per tablet Prescription only Select

How to use Migard Tablets

It’s important to read the enclosed leaflet carefully before using Migard Tablets.

The dose is one 2.5mg tablet, taken with liquid, as soon as possible after your migraine headache starts. However it can still be effective if you take it at a later stage of the headache. It doesn’t matter if you take it with or without food.

If you have another headache later, a second tablet can be taken; but you should not take more than one tablet per migraine attack. The second tablet should not be taken within 2 hours of the first tablet, and don’t take more than 2 tablets (5mg) in any 24 hour period.

Are Migard Tablets suitable for me?

There are some situations where Migard Tablets, like all medicines, should be used with caution or would not be recommended, for example in people aged under 18 or over 65; people who have now (or who have had in the past) heart problems including stroke, transient ischaemic attack, angina, heart attack, or high blood pressure; people with liver or kidney problems, and people who are allergic to any of the active or inactive ingredients. Some people with risk factors for heart disease may not be suitable for treatment with Migard Tablets, for example people who are heavy smokers or who use nicotine replacement therapies, especially when they are women after the menopause or men over 40, or where there is a strong family history of heart disease.

During your consultation, it is important to tell us if you are taking any other medicines, either from your doctor or purchased from a pharmacy without a prescription. Migard Tablets can cause problems if taken with certain other medicines, including some other medicines for migraines (methysergide, ergotamine, other triptans), some antidepressant medicines (fluvoxamine, MAOI’s, and also SSRI’s and SNRI’s, which may also be prescribed for anxiety), or St John’s Wort supplements.

It is important to mention during the consultation if you are pregnant or think you might be pregnant, or are breast-feeding or planning to breast-feed.

If it doesn’t work for you, tell the doctor because a different treatment might be better.

It’s very important to give a full picture of your general health in the consultation, to make sure the doctor has all the information required to assess the suitability of Migard Tablets for you.

Migard Tablets side effects

Like all medicines, Migard Tablets can cause side effects, although not everybody gets them.

Side effects that are considered to be common include dizziness, tiredness, pins and needles, headaches, flushing, throat tightness, nausea, dry mouth, indigestion, stomach pain, excess sweating, chest discomfort, and visual disturbances; although some of these may be associated with the migraine itself.

Other less common side effects can include anxiety, dehydration, tremor, vertigo, eye irritation, ear ringing or pain, diarrhoea, skin itching, and back or muscle pain. If you experience any persistent or troublesome side effects you should stop using Migard Tablets and talk to your doctor.

For a full list of potential side effects and other important information, please read the patient information leaflet provided in the pack before starting any course of treatment. The leaflet can also be viewed online here:
http://xpil.medicines.org.uk/viewpil.aspx?docid=15211